MedPath

Smoking Cessation for Smokers With Sleep Problems

Not Applicable
Completed
Conditions
Cigarette Smoking
Nicotine Dependence
Insomnia
Interventions
Behavioral: Smoking Cessation Counseling
Behavioral: Cognitive-Behavioral Counseling
Registration Number
NCT01277887
Lead Sponsor
Yale University
Brief Summary

This is a pilot research study examining two types of behavioral counseling along with the nicotine patch for smoking cessation. The study is designed to find out whether one of these counseling interventions is more effective for smoking cessation among individuals with sleep problems. The study has three parts: 1) an intake session; 2) a 10-week treatment phase, and 3) a 1-month follow-up.

Detailed Description

This is a developmental study to: 1) create and test an integrated cognitive-behavioral smoking cessation and insomnia intervention with 30 smokers who report current insomnia. Participants are randomized to 1 of 2 counseling conditions. The cognitive-behavioral intervention provides standard care smoking counseling along with counseling to address insomnia. The smoking counseling intervention provides standard care smoking counseling adapted from the American Lung Association Freedom from Smoking program. Efficacy data from this trial will be used to determine effect size estimates for biologically confirmed self-reported point prevalence smoking abstinence at the end of treatment and 1 month after completing treatment. Changes in sleep efficiency and self-control to resist smoking urges will also be examined. If the effect size estimates are sufficiently large and medically important to pursue a definitive trial, these data will be used to propose a full scale large study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Between the ages of 18 and 75.
  • Smoking 10 or more cigarettes per day for at least 1 year.
  • An expired air breath carbon monoxide level > 10 ppm.
  • Motivated to stop smoking.
  • Understand English.
  • Meet DSM-IV criteria for insomnia.
  • Report sleep latency or waking after sleep onset >30 minutes on ≥6 occasions within past month.
Read More
Exclusion Criteria
  • History of allergic reactions to adhesives.
  • Unstable psychiatric/medical conditions such as current suicidal or homicidal ideation, acute psychosis, dementia.
  • Have a current diagnosis of DSM-IV alcohol or drug dependence other than nicotine.
  • Use of tobacco products other than cigarettes or use of marijuana.
  • Intention to use nicotine replacement therapy, varenicline, or bupropion during study participation.
  • Females of childbearing potential who are pregnant, nursing, or not practicing effective contraception (oral, injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide).
  • New onset of psychiatric disorders or new psychotropic medications within the past 3 months.
  • Inability to read/understand English.
  • History of sleep apnea based on responses to Berlin Questionnaire.
  • History of restless leg syndrome.
  • Current night or rotating shift work.
  • Proposed travel across 2 or more time zones during study participation.
  • Medical/psychiatric conditions contraindicated for sleep restriction (i.e., seizure disorders, severe excessive daytime sleepiness - Epworth Scale >18, and bipolar disorder).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Smoking Cessation CounselingSmoking Cessation CounselingThe intervention consists of 8 sessions provided over 10 weeks. Counseling commences 4 weeks before quitting smoking. Participants will also receive the nicotine patch for 6 weeks starting on the day of quit date.
Cognitive-Behavioral CounselingCognitive-Behavioral CounselingThe intervention consists of 8 sessions provided over 10 weeks. Counseling commences 4 weeks before quitting smoking. Participants will also receive the nicotine patch for 6 weeks starting on the day of quit date.
Primary Outcome Measures
NameTimeMethod
Smoking Abstinence1 Week

Smoking abstinence is operationally defined as "no smoking on the last 7 days of the last week of treatment. And no smoking within the last 7 days at the first follow-up visit 4 weeks after completing treatment."

Secondary Outcome Measures
NameTimeMethod
Self-Control to Resist Smoking Cues4 Weeks

To develop an effect size estimate for changes in self-control to resist smoking cues from baseline to the day before quitting smoking comparing smokers in the two counseling conditions.

Sleep EfficiencyChange from Baseline at 4 weeks

Self-reported sleep efficiency subscale of the Pittsburgh Sleep Quality Index. This is calculated as the percentage of total time spent asleep in a night compared to the total time spent in bed, multiplied by 100.

Trial Locations

Locations (1)

Yale University School of Medicine

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath